Header Logo

Connection

Mark Pollack to Male

This is a "connection" page, showing publications Mark Pollack has written about Male.
Connection Strength

2.763
  1. Examining Insomnia During Intensive Treatment for Veterans with Posttraumatic Stress Disorder: Does it Improve and Does it Predict Treatment Outcomes? J Trauma Stress. 2020 08; 33(4):521-527.
    View in: PubMed
    Score: 0.055
  2. "I knew it was wrong the moment I got the order": A narrative thematic analysis of moral injury in combat veterans. Psychol Trauma. 2019 May; 11(4):396-405.
    View in: PubMed
    Score: 0.048
  3. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255.
    View in: PubMed
    Score: 0.047
  4. Physiological reactivity to nonideographic virtual reality stimuli in veterans with and without PTSD. Brain Behav. 2015 Feb; 5(2):e00304.
    View in: PubMed
    Score: 0.038
  5. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):402-11.
    View in: PubMed
    Score: 0.038
  6. Response to Silberman. Am J Psychiatry. 2014 Jul; 171(7):795-6.
    View in: PubMed
    Score: 0.037
  7. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53.
    View in: PubMed
    Score: 0.036
  8. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. J Consult Clin Psychol. 2013 Dec; 81(6):1100-12.
    View in: PubMed
    Score: 0.035
  9. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am J Psychiatry. 2013 Jul; 170(7):751-8.
    View in: PubMed
    Score: 0.034
  10. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012 Jun; 80(3):404-15.
    View in: PubMed
    Score: 0.032
  11. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
    View in: PubMed
    Score: 0.031
  12. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Jul; 72(7):892-7.
    View in: PubMed
    Score: 0.029
  13. Khy?l attacks: a key idiom of distress among traumatized cambodia refugees. Cult Med Psychiatry. 2010 Jun; 34(2):244-78.
    View in: PubMed
    Score: 0.028
  14. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7.
    View in: PubMed
    Score: 0.028
  15. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31.
    View in: PubMed
    Score: 0.027
  16. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010 Feb 15; 67(4):365-70.
    View in: PubMed
    Score: 0.026
  17. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. J Clin Psychiatry. 2009 Nov; 70(11):1563-70.
    View in: PubMed
    Score: 0.026
  18. Nightmares among Cambodian refugees: the breaching of concentric ontological security. Cult Med Psychiatry. 2009 Jun; 33(2):219-65.
    View in: PubMed
    Score: 0.026
  19. Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):427-34.
    View in: PubMed
    Score: 0.025
  20. Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther. 2009; 15(1):19-23.
    View in: PubMed
    Score: 0.025
  21. A model of the generation of ataque de nervios: the role of fear of negative affect and fear of arousal symptoms. CNS Neurosci Ther. 2009; 15(3):264-75.
    View in: PubMed
    Score: 0.025
  22. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
    View in: PubMed
    Score: 0.024
  23. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62.
    View in: PubMed
    Score: 0.024
  24. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J Psychiatr Res. 2008 Oct; 42(14):1176-84.
    View in: PubMed
    Score: 0.024
  25. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar; 69(3):400-5.
    View in: PubMed
    Score: 0.024
  26. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.
    View in: PubMed
    Score: 0.024
  27. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res. 2008 Oct; 42(12):1042-9.
    View in: PubMed
    Score: 0.024
  28. Orthostatic panic attacks among Vietnamese refugees. Transcult Psychiatry. 2007 Dec; 44(4):515-44.
    View in: PubMed
    Score: 0.023
  29. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 01; 32(3):739-43.
    View in: PubMed
    Score: 0.023
  30. Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007 Jul; 68(7):1010-3.
    View in: PubMed
    Score: 0.023
  31. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42.
    View in: PubMed
    Score: 0.023
  32. Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001. Med Anthropol Q. 2007 Mar; 21(1):81-107.
    View in: PubMed
    Score: 0.022
  33. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb; 27(1):85-8.
    View in: PubMed
    Score: 0.022
  34. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety. 2007; 24(1):1-14.
    View in: PubMed
    Score: 0.022
  35. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. J Nerv Ment Dis. 2006 Dec; 194(12):951-7.
    View in: PubMed
    Score: 0.022
  36. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):255-64.
    View in: PubMed
    Score: 0.022
  37. An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
    View in: PubMed
    Score: 0.021
  38. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. 2006 Mar; 67(3):394-9.
    View in: PubMed
    Score: 0.021
  39. Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Depress Anxiety. 2006; 23(2):113-5.
    View in: PubMed
    Score: 0.020
  40. Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. J Anxiety Disord. 2006; 20(2):119-38.
    View in: PubMed
    Score: 0.020
  41. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depress Anxiety. 2006; 23(6):373-6.
    View in: PubMed
    Score: 0.020
  42. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. J Trauma Stress. 2005 Dec; 18(6):617-29.
    View in: PubMed
    Score: 0.020
  43. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8.
    View in: PubMed
    Score: 0.020
  44. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry. 2006 Feb 01; 59(3):211-5.
    View in: PubMed
    Score: 0.020
  45. Rates of isolated sleep paralysis in outpatients with anxiety disorders. J Anxiety Disord. 2006; 20(5):687-93.
    View in: PubMed
    Score: 0.020
  46. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 2005 Jul-Aug; 46(4):334-9.
    View in: PubMed
    Score: 0.020
  47. 'The ghost pushes you down': sleep paralysis-type panic attacks in a Khmer refugee population. Transcult Psychiatry. 2005 Mar; 42(1):46-77.
    View in: PubMed
    Score: 0.019
  48. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11.
    View in: PubMed
    Score: 0.019
  49. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004 Dec; 161(12):2222-9.
    View in: PubMed
    Score: 0.019
  50. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004 Oct; 17(5):429-33.
    View in: PubMed
    Score: 0.019
  51. An open-label study of levetiracetam for the treatment of social anxiety disorder. J Clin Psychiatry. 2004 Sep; 65(9):1219-22.
    View in: PubMed
    Score: 0.019
  52. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res. 2004 Sep-Oct; 38(5):491-5.
    View in: PubMed
    Score: 0.019
  53. Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcult Psychiatry. 2004 Jun; 41(2):155-99.
    View in: PubMed
    Score: 0.018
  54. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82.
    View in: PubMed
    Score: 0.017
  55. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. J Clin Psychopharmacol. 2003 Jun; 23(3):250-9.
    View in: PubMed
    Score: 0.017
  56. Relationship between adult social phobia and childhood anxiety. Braz J Psychiatry. 2003 Jun; 25(2):96-9.
    View in: PubMed
    Score: 0.017
  57. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 2003 May-Jun; 44(3):222-36.
    View in: PubMed
    Score: 0.017
  58. Bupropion sustained release for panic disorder. Psychopharmacol Bull. 2003; 37(4):66-72.
    View in: PubMed
    Score: 0.017
  59. A novel cognitive-behavioral approach for treatment-resistant drug dependence. J Subst Abuse Treat. 2002 Dec; 23(4):335-42.
    View in: PubMed
    Score: 0.016
  60. History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. J Nerv Ment Dis. 2002 Jul; 190(7):453-6.
    View in: PubMed
    Score: 0.016
  61. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002 Jul-Aug; 36(4):229-36.
    View in: PubMed
    Score: 0.016
  62. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv. 2002 Jun; 53(6):714-8.
    View in: PubMed
    Score: 0.016
  63. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002 May; 69(1-3):201-8.
    View in: PubMed
    Score: 0.016
  64. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord. 2002 May; 69(1-3):209-17.
    View in: PubMed
    Score: 0.016
  65. Citalopram for social phobia: a clinical case series. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct; 25(7):1469-74.
    View in: PubMed
    Score: 0.015
  66. The anxiety sensitivity index: item analysis and suggestions for refinement. J Pers Assess. 2001 Oct; 77(2):272-94.
    View in: PubMed
    Score: 0.015
  67. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001 May; 62(5):350-7.
    View in: PubMed
    Score: 0.015
  68. Prevalence of childhood ADHD among patients with Generalized Anxiety Disorder and a comparison condition, Social Phobia. Depress Anxiety. 2001; 13(4):190-1.
    View in: PubMed
    Score: 0.014
  69. Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 12:24-9.
    View in: PubMed
    Score: 0.014
  70. Sertraline treatment of panic disorder: response in patients at risk for poor outcome. J Clin Psychiatry. 2000 Dec; 61(12):922-7.
    View in: PubMed
    Score: 0.014
  71. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e206777.
    View in: PubMed
    Score: 0.014
  72. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019 Nov/Dec; 13(6):460-463.
    View in: PubMed
    Score: 0.013
  73. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729.
    View in: PubMed
    Score: 0.013
  74. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.013
  75. Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD. Psychol Trauma. 2020 May; 12(4):422-430.
    View in: PubMed
    Score: 0.013
  76. Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999 Jul; 187(7):429-34.
    View in: PubMed
    Score: 0.013
  77. Collaborative Care for Depression of Adults and Adolescents: Measuring the Effectiveness of Screening and Treatment Uptake. Psychiatr Serv. 2019 07 01; 70(7):604-607.
    View in: PubMed
    Score: 0.013
  78. A placebo-controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 07; 36(7):617-624.
    View in: PubMed
    Score: 0.013
  79. An Open Trial of Morning Bright Light Treatment Among US Military Veterans with Chronic Low Back Pain: A Pilot Study. Pain Med. 2019 04 01; 20(4):770-778.
    View in: PubMed
    Score: 0.013
  80. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998 Nov; 55(11):1010-6.
    View in: PubMed
    Score: 0.012
  81. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242.
    View in: PubMed
    Score: 0.012
  82. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3.
    View in: PubMed
    Score: 0.012
  83. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther. 1998 Jul-Aug; 36(7-8):665-73.
    View in: PubMed
    Score: 0.012
  84. How do clinicians respond to patients who miss appointments? J Clin Psychiatry. 1998 Jun; 59(6):330-8; quiz 339-40.
    View in: PubMed
    Score: 0.012
  85. Negative posttraumatic cognitions among military sexual trauma survivors. J Affect Disord. 2018 10 01; 238:88-93.
    View in: PubMed
    Score: 0.012
  86. Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. Child Psychiatry Hum Dev. 2018 04; 49(2):209-216.
    View in: PubMed
    Score: 0.012
  87. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addict Behav. 2018 09; 84:75-78.
    View in: PubMed
    Score: 0.012
  88. Nefazodone for social phobia: a clinical case series. Depress Anxiety. 1998; 8(3):131-3.
    View in: PubMed
    Score: 0.012
  89. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5.
    View in: PubMed
    Score: 0.012
  90. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction? J Anxiety Disord. 2018 01; 53:85-90.
    View in: PubMed
    Score: 0.012
  91. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997 Sep-Oct; 11(5):499-502.
    View in: PubMed
    Score: 0.011
  92. Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359.
    View in: PubMed
    Score: 0.011
  93. Selective encoding of threat in panic disorder: application of a dual priming paradigm. Behav Res Ther. 1997 Jun; 35(6):543-9.
    View in: PubMed
    Score: 0.011
  94. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 04; 262:328-332.
    View in: PubMed
    Score: 0.011
  95. Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety. J Psychosom Res. 2017 04; 95:7-11.
    View in: PubMed
    Score: 0.011
  96. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. J Clin Psychiatry. 1997; 58 Suppl 11:19-23.
    View in: PubMed
    Score: 0.011
  97. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996 Nov 25; 41(2):135-9.
    View in: PubMed
    Score: 0.011
  98. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45.
    View in: PubMed
    Score: 0.011
  99. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. J Trauma Stress. 2016 06; 29(3):268-72.
    View in: PubMed
    Score: 0.010
  100. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. Behav Res Ther. 2016 06; 81:21-34.
    View in: PubMed
    Score: 0.010
  101. Prevalence of panic in patients referred for pulmonary function testing at a major medical center. Am J Psychiatry. 1996 Jan; 153(1):110-3.
    View in: PubMed
    Score: 0.010
  102. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull. 1996; 32(4):667-70.
    View in: PubMed
    Score: 0.010
  103. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychol Rep. 2015 Oct; 117(2):473-89.
    View in: PubMed
    Score: 0.010
  104. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016 May; 21(5):680-5.
    View in: PubMed
    Score: 0.010
  105. Altered resting-state functional connectivity of the frontal-striatal reward system in social anxiety disorder. PLoS One. 2015; 10(4):e0125286.
    View in: PubMed
    Score: 0.010
  106. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5.
    View in: PubMed
    Score: 0.009
  107. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5.
    View in: PubMed
    Score: 0.009
  108. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry. 2014 Dec 01; 76(11):902-10.
    View in: PubMed
    Score: 0.009
  109. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behav Ther. 2014 Sep; 45(5):619-29.
    View in: PubMed
    Score: 0.009
  110. Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology. 2014 May; 39(6):1340-6.
    View in: PubMed
    Score: 0.009
  111. Smiles may go unseen in generalized social anxiety disorder: evidence from binocular rivalry for reduced visual consciousness of positive facial expressions. J Anxiety Disord. 2013 Oct; 27(7):619-26.
    View in: PubMed
    Score: 0.009
  112. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993 Aug; 13(4):257-63.
    View in: PubMed
    Score: 0.009
  113. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug; 74(8):786-92.
    View in: PubMed
    Score: 0.009
  114. Cortico-limbic responses to masked affective faces across ptsd, panic disorder, and specific phobia. Depress Anxiety. 2014 Feb; 31(2):150-9.
    View in: PubMed
    Score: 0.009
  115. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. J Psychiatr Res. 2013 Oct; 47(10):1455-61.
    View in: PubMed
    Score: 0.009
  116. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56.
    View in: PubMed
    Score: 0.009
  117. Development of a brief version of the Social Phobia Inventory using item response theory: the Mini-SPIN-R. Behav Ther. 2013 Dec; 44(4):651-61.
    View in: PubMed
    Score: 0.008
  118. Voxel-based morphometric gray matter correlates of posttraumatic stress disorder. J Anxiety Disord. 2013 May; 27(4):413-9.
    View in: PubMed
    Score: 0.008
  119. Loving-Kindness Meditation practice associated with longer telomeres in women. Brain Behav Immun. 2013 Aug; 32:159-63.
    View in: PubMed
    Score: 0.008
  120. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry. 2013 Jun 01; 73(11):1054-8.
    View in: PubMed
    Score: 0.008
  121. Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. JAMA Psychiatry. 2013 Jan; 70(1):87-97.
    View in: PubMed
    Score: 0.008
  122. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. Am J Addict. 2013 Jan; 22(1):18-22.
    View in: PubMed
    Score: 0.008
  123. Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res. 2013 Feb; 47(2):168-74.
    View in: PubMed
    Score: 0.008
  124. Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depress Anxiety. 2012 Nov; 29(11):924-30.
    View in: PubMed
    Score: 0.008
  125. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. J Psychoactive Drugs. 2012 Jul-Aug; 44(3):237-42.
    View in: PubMed
    Score: 0.008
  126. Avoidant personality disorder in individuals with generalized social anxiety disorder: what does it add? J Anxiety Disord. 2012 Aug; 26(6):665-72.
    View in: PubMed
    Score: 0.008
  127. Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83.
    View in: PubMed
    Score: 0.008
  128. Anchoring the Panic Disorder Severity Scale. Assessment. 2012 Jun; 19(2):257-9.
    View in: PubMed
    Score: 0.008
  129. Mood regulation and quality of life in social anxiety disorder: an examination of generalized expectancies for negative mood regulation. J Anxiety Disord. 2012 Apr; 26(3):435-41.
    View in: PubMed
    Score: 0.008
  130. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med. 1992; 22(4):305-27.
    View in: PubMed
    Score: 0.008
  131. Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD. Depress Anxiety. 2012 Feb; 29(2):147-54.
    View in: PubMed
    Score: 0.008
  132. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. J Clin Psychiatry. 2012 Mar; 73(3):353-7.
    View in: PubMed
    Score: 0.008
  133. Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder. J Anxiety Disord. 2011 Dec; 25(8):1072-8.
    View in: PubMed
    Score: 0.007
  134. The role of anxiety sensitivity in sleep disturbance in panic disorder. J Anxiety Disord. 2011 May; 25(4):536-8.
    View in: PubMed
    Score: 0.007
  135. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7.
    View in: PubMed
    Score: 0.007
  136. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry. 1991 Jan; 52(1):31-3.
    View in: PubMed
    Score: 0.007
  137. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther. 2010 Oct; 16(5):322-5.
    View in: PubMed
    Score: 0.007
  138. Anger, PTSD, and the nuclear family: a study of Cambodian refugees. Soc Sci Med. 2009 Nov; 69(9):1387-94.
    View in: PubMed
    Score: 0.007
  139. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009; 26(5):447-55.
    View in: PubMed
    Score: 0.006
  140. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. CNS Neurosci Ther. 2009; 15(2):100-6.
    View in: PubMed
    Score: 0.006
  141. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009; 15(3):255-63.
    View in: PubMed
    Score: 0.006
  142. Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depress Anxiety. 2009; 26(11):1027-32.
    View in: PubMed
    Score: 0.006
  143. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol. 2008 Aug; 23(6):519-26.
    View in: PubMed
    Score: 0.006
  144. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology. 2009 Jan; 34(2):390-8.
    View in: PubMed
    Score: 0.006
  145. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
    View in: PubMed
    Score: 0.006
  146. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.006
  147. Anhedonic ejaculation with desipramine. Int J Psychiatry Med. 1988; 18(1):85-8.
    View in: PubMed
    Score: 0.006
  148. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety. 2008; 25(2):167-71.
    View in: PubMed
    Score: 0.006
  149. Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depress Anxiety. 2008; 25(6):489-95.
    View in: PubMed
    Score: 0.006
  150. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety. 2008; 25(6):496-505.
    View in: PubMed
    Score: 0.006
  151. The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugees. Cogn Behav Ther. 2008; 37(2):101-16.
    View in: PubMed
    Score: 0.006
  152. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther. 2008; 14(3):165-70.
    View in: PubMed
    Score: 0.006
  153. Complicated grief and impaired sleep in patients with bipolar disorder. Bipolar Disord. 2007 Dec; 9(8):913-7.
    View in: PubMed
    Score: 0.006
  154. Clonazepam: a review of open clinical trials. J Clin Psychiatry. 1987 Oct; 48 Suppl:12-5.
    View in: PubMed
    Score: 0.006
  155. Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord. 2008 Jun; 22(5):868-76.
    View in: PubMed
    Score: 0.006
  156. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008 Mar; 18(3):230-3.
    View in: PubMed
    Score: 0.006
  157. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Curr Med Res Opin. 2007 Jun; 23(6):1431-43.
    View in: PubMed
    Score: 0.006
  158. Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. J Anxiety Disord. 2007; 21(7):888-902.
    View in: PubMed
    Score: 0.005
  159. Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm. Behav Modif. 2007 Jan; 31(1):32-51.
    View in: PubMed
    Score: 0.005
  160. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
    View in: PubMed
    Score: 0.005
  161. Management of antidepressant-induced side effects: a practical guide for the clinician. J Clin Psychiatry. 1987 Jan; 48(1):3-8.
    View in: PubMed
    Score: 0.005
  162. Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. J Nerv Ment Dis. 2006 Dec; 194(12):962-6.
    View in: PubMed
    Score: 0.005
  163. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4.
    View in: PubMed
    Score: 0.005
  164. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007 Jan; 97(1-3):91-9.
    View in: PubMed
    Score: 0.005
  165. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
    View in: PubMed
    Score: 0.005
  166. Oculocutaneous albinism and schizophrenia. Biol Psychiatry. 1986 Jul; 21(8-9):830-3.
    View in: PubMed
    Score: 0.005
  167. Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. J Affect Disord. 2006 Aug; 94(1-3):191-7.
    View in: PubMed
    Score: 0.005
  168. Assessment of posttraumatic stress disorder in Cambodian refugees using the Clinician-Administered PTSD Scale: psychometric properties and symptom severity. J Trauma Stress. 2006 Jun; 19(3):405-9.
    View in: PubMed
    Score: 0.005
  169. Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. J Anxiety Disord. 2007; 21(1):42-58.
    View in: PubMed
    Score: 0.005
  170. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May; 14(2):157-64.
    View in: PubMed
    Score: 0.005
  171. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5.
    View in: PubMed
    Score: 0.005
  172. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006 Mar; 63(3):298-304.
    View in: PubMed
    Score: 0.005
  173. Anxiety sensitivity among Cambodian refugees with panic disorder: A factor analytic investigation. J Anxiety Disord. 2006; 20(3):281-95.
    View in: PubMed
    Score: 0.005
  174. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl). 2006 Jan; 184(2):139-44.
    View in: PubMed
    Score: 0.005
  175. Anxiety sensitivity in traumatized Cambodian refugees: a discriminant function and factor analytic investigation. Behav Res Ther. 2005 Dec; 43(12):1631-43.
    View in: PubMed
    Score: 0.005
  176. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry. 2005 Sep; 62(9):1022-30.
    View in: PubMed
    Score: 0.005
  177. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005 Sep; 66(9):1105-10.
    View in: PubMed
    Score: 0.005
  178. Childhood antecedents to panic disorder in referred and nonreferred adults. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):549-61.
    View in: PubMed
    Score: 0.005
  179. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005 Jul; 87(1):101-5.
    View in: PubMed
    Score: 0.005
  180. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73.
    View in: PubMed
    Score: 0.005
  181. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
    View in: PubMed
    Score: 0.005
  182. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985 Feb; 173(2):118-9.
    View in: PubMed
    Score: 0.005
  183. Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample. Depress Anxiety. 2005; 21(2):55-60.
    View in: PubMed
    Score: 0.005
  184. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depress Anxiety. 2005; 22(2):47-51.
    View in: PubMed
    Score: 0.005
  185. Parental predictors of pediatric panic disorder/agoraphobia: a controlled study in high-risk offspring. Depress Anxiety. 2005; 22(3):114-20.
    View in: PubMed
    Score: 0.005
  186. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
    View in: PubMed
    Score: 0.005
  187. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Res. 2004 Sep 15; 131(3):217-26.
    View in: PubMed
    Score: 0.005
  188. Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinic. Gen Hosp Psychiatry. 2004 Sep-Oct; 26(5):390-7.
    View in: PubMed
    Score: 0.005
  189. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004 Jul 30; 131(2):135-45.
    View in: PubMed
    Score: 0.005
  190. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl). 2005 Jan; 177(3):280-8.
    View in: PubMed
    Score: 0.005
  191. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30; 126(2):143-9.
    View in: PubMed
    Score: 0.005
  192. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004 Apr; 24(2):141-9.
    View in: PubMed
    Score: 0.005
  193. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
    View in: PubMed
    Score: 0.004
  194. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003 May; 18(3):169-72.
    View in: PubMed
    Score: 0.004
  195. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.004
  196. Ropinirole for antidepressant-induced sexual dysfunction. Int Clin Psychopharmacol. 2002 Nov; 17(6):307-10.
    View in: PubMed
    Score: 0.004
  197. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9.
    View in: PubMed
    Score: 0.004
  198. Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 2002 Mar-Apr; 10(2):109-14.
    View in: PubMed
    Score: 0.004
  199. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. 2001 Oct; 104(4):289-98.
    View in: PubMed
    Score: 0.004
  200. Feeling sick: the experience and legitimation of illness. Soc Sci Med A. 1981 May; 15(3 Pt 1):243-51.
    View in: PubMed
    Score: 0.004
  201. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet. 2001 Mar 08; 105(2):195-206.
    View in: PubMed
    Score: 0.004
  202. Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines. J Clin Psychopharmacol. 2001 Feb; 21(1):104-7.
    View in: PubMed
    Score: 0.004
  203. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anxiety. 2001; 14(4):209-13.
    View in: PubMed
    Score: 0.004
  204. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug; 20(4):467-71.
    View in: PubMed
    Score: 0.004
  205. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol. 2000 Aug; 68(4):556-63.
    View in: PubMed
    Score: 0.004
  206. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord. 2000 Jul-Aug; 14(4):345-58.
    View in: PubMed
    Score: 0.003
  207. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry. 2000 Jun; 157(6):968-74.
    View in: PubMed
    Score: 0.003
  208. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord. 2000 May; 58(2):99-106.
    View in: PubMed
    Score: 0.003
  209. Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depress Anxiety. 2000; 11(1):31-7.
    View in: PubMed
    Score: 0.003
  210. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
    View in: PubMed
    Score: 0.003
  211. Is panic disorder linked to cognitive avoidance of threatening information? J Anxiety Disord. 1999 Jul-Aug; 13(4):335-48.
    View in: PubMed
    Score: 0.003
  212. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Res. 1999 Jun 30; 90(3):143-52.
    View in: PubMed
    Score: 0.003
  213. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May; 156(5):756-60.
    View in: PubMed
    Score: 0.003
  214. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. Br J Psychiatry. 1999 Mar; 174:213-8.
    View in: PubMed
    Score: 0.003
  215. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest. 1979 Feb; 63(2):276-86.
    View in: PubMed
    Score: 0.003
  216. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry. 1998 Nov; 155(11):1570-7.
    View in: PubMed
    Score: 0.003
  217. Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. J Anxiety Disord. 1998 May-Jun; 12(3):225-32.
    View in: PubMed
    Score: 0.003
  218. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998 Jan-Feb; 39(1):24-9.
    View in: PubMed
    Score: 0.003
  219. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull. 1998; 34(2):199-205.
    View in: PubMed
    Score: 0.003
  220. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol. 1997 Aug; 17(4):247-54.
    View in: PubMed
    Score: 0.003
  221. Panic disorder in emergency ward patients with chest pain. J Nerv Ment Dis. 1997 Apr; 185(4):274-6.
    View in: PubMed
    Score: 0.003
  222. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Infect Immun. 1976 Oct; 14(4):942-7.
    View in: PubMed
    Score: 0.003
  223. Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996 Jun 20; 39(1):31-8.
    View in: PubMed
    Score: 0.003
  224. EEG abnormalities in patients with atypical panic attacks. J Clin Psychiatry. 1995 Aug; 56(8):358-62.
    View in: PubMed
    Score: 0.002
  225. Hemispheric laterality and memory bias for threat in anxiety disorders. J Abnorm Psychol. 1994 Nov; 103(4):828-831.
    View in: PubMed
    Score: 0.002
  226. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6.
    View in: PubMed
    Score: 0.002
  227. Sleep panic attacks: an association with childhood anxiety and adult psychopathology. Biol Psychiatry. 1994 Jul 01; 36(1):57-60.
    View in: PubMed
    Score: 0.002
  228. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65.
    View in: PubMed
    Score: 0.002
  229. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93.
    View in: PubMed
    Score: 0.002
  230. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
    View in: PubMed
    Score: 0.002
  231. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
    View in: PubMed
    Score: 0.002
  232. Focal paroxysmal EEG changes during atypical panic attacks. J Neuropsychiatry Clin Neurosci. 1993; 5(1):50-5.
    View in: PubMed
    Score: 0.002
  233. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec; 166(6):1429-33.
    View in: PubMed
    Score: 0.002
  234. Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38.
    View in: PubMed
    Score: 0.002
  235. Major depression in panic disorder patients with comorbid social phobia. J Affect Disord. 1991 Jul; 22(3):171-7.
    View in: PubMed
    Score: 0.002
  236. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76.
    View in: PubMed
    Score: 0.002
  237. Clonazepam for the treatment of social phobia. J Clin Psychiatry. 1990 Nov; 51(11):470-2.
    View in: PubMed
    Score: 0.002
  238. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6.
    View in: PubMed
    Score: 0.002
  239. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990; 24(2):177-84.
    View in: PubMed
    Score: 0.002
  240. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990 Jan; 51(1):25-7.
    View in: PubMed
    Score: 0.002
  241. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
    View in: PubMed
    Score: 0.002
  242. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 1989 Jun; 28(3):345-50.
    View in: PubMed
    Score: 0.002
  243. Siblings of schizophrenic and nonschizophrenic psychiatric patients. Psychopathology and gender concordance. Arch Gen Psychiatry. 1969 Jun; 20(6):652-8.
    View in: PubMed
    Score: 0.002
  244. Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan; 146(1):122.
    View in: PubMed
    Score: 0.002
  245. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6.
    View in: PubMed
    Score: 0.002
  246. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94.
    View in: PubMed
    Score: 0.001
  247. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6.
    View in: PubMed
    Score: 0.001
  248. Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
    View in: PubMed
    Score: 0.001
  249. Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiatry. 1966 Apr; 122(10):1102-9.
    View in: PubMed
    Score: 0.001
  250. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1980 Dec; 51(6):1316-24.
    View in: PubMed
    Score: 0.001
  251. Birth weight and length in schizophrenics personality disorders and their siblings. Br J Psychiatry. 1971 Apr; 118(545):461-4.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.